Amendment sought to require reasonable price agreements for the sale of drugs developed by NIH.

Ask AI
Amendment Number
1273
Description
Amendment sought to require reasonable price agreements for the sale of drugs developed by NIH.
Purpose
An amendment, printed as amendment No. 12 in the Congressional Record of July 9, 1996 to prohibit the use of funds appropriated in the bill to be used by the Secretary of Health and Human Services to enter into an agreement to grant a private company exlusive rights to market drugs developed by the National Institutes of Health, unless the sale of the the drug is subject to a reasonable price agreement, or such an agreement is determined to be not required.
Congress
104
Type
HAMDT
Latest Action Date
Jul 11, 1996
Latest Action Text
On agreeing to the Sanders amendment (A024) Failed by recorded vote: 180 - 242 (Roll no. 306).
Latest Action Time
23:32:09
Submitted Date
Jul 11, 1996
Chamber
House of Representatives
Update Date
Aug 15, 2021
Amendment 1273 — Informed